Genenta Science S.p.A. announced the nomination of Mark A. Sirgo, PharmD, an executive leader with over 35 years of pharmaceutical industry experience, as its new Chair. Stephen Squinto, PhD is stepping down from his role as Chair on May 1, 2022 to pursue a new business opportunity. Dr. Sirgo most recently was CEO of Aruna Bio Inc., a preclinical biotech company developing neural stem cells for the treatment of neurological disorders.

He previously founded and spent 13 years as CEO of the specialty pharmaceutical company Biodelivery Sciences Inc.